SHAH NIKITA (Executive Vice President) sold 36.6% of their position (146.40K shares) of AMNEAL PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $2.56M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/13/2026ACC: 0001628280-26-056757
Officer· Executive Vice President
Since Mar 2026
-146.40K
Net shares
Net seller
$2.56M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
146.40K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−146.40K
Price / share
$17.51
Trade value
$2.56M
% of position
36.6%
8/12/2026
399.79K→253.39K
Total
Net shares
−146.40K
Net value
-$2.56M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 8/12/2026 | S · Sale | −146.40K | $17.51 | $2.56M | 36.6% | 399.79K | 253.39K |
| Total | −146.40K | -$2.56M | ||||||
Derivative Transactions0
No derivative transactions reported